Sign inGet started

MARCHIO ALBERT N II

Insider CIK 1196054 · EDGE Chief Acct. & Op., Asst. Sec. · BBI Chief Financial Officer, Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
FRTX Fresh Tracks Therapeutics, D To issuer deriv2023-12-282024-01-091,250$0.91 $1.1K0SEC↗
FRTX Fresh Tracks Therapeutics, A Award deriv2023-01-242023-01-261,250— $01,250SEC↗
BBI Brickell Biotech, Inc. A Award deriv2022-05-052022-05-0930,000— $030,000SEC↗
BBI Brickell Biotech, Inc. A Award deriv2021-06-142021-06-1420,000— $020,000SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2018-08-142018-08-1541,666— $041,666SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2018-06-192018-06-2083,334— $083,334SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2018-03-012018-03-0525,000— $025,000SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2018-01-022018-01-0350,000— $050,000SEC↗
EDGE Edge Therapeutics, Inc. S Sale2017-11-222017-11-223,361$10.00 $33.6K0SEC↗
EDGE Edge Therapeutics, Inc. S Sale2017-08-292017-08-292,500$10.42 $26.1K3,361SEC↗
EDGE Edge Therapeutics, Inc. S Sale2017-08-232017-08-241,000$10.39 $10.4K5,861SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2017-03-132017-03-1547,500$8.86 $420.9K47,500SEC↗
EDGE Edge Therapeutics, Inc. A Award deriv2016-02-162016-02-1835,000— $035,000SEC↗
EDGE Edge Therapeutics, Inc. C Conversion deriv2015-10-062015-10-087,530— $00SEC↗
EDGE Edge Therapeutics, Inc. P Buy2015-10-062015-10-08100$11.00 $1.1K6,504SEC↗
EDGE Edge Therapeutics, Inc. J Other2015-10-062015-10-08357$7.24 $2.6K6,861SEC↗
EDGE Edge Therapeutics, Inc. C Conversion2015-10-062015-10-085,504— $05,504SEC↗